Dave & Buster’s stock soars 28% after COVID-19 vaccine trial announced

<p>Dave & Buster’s Entertainment Inc. PLAY, -1.07% shares surged 28.7% on Monday in pre-release after Pfizer Inc. PFE, + 0.02% and BioNTech SE BNTX, announced a vaccine trial COVID-19 “passed”. Dave & Buster’s struggled during the pandemic, with many locations still closed in early October and comparable sales in September down 62%. Dave & Buster’s stock fell by more than half in 2020, down 54%, while the S&P 500 SPX index, -0.02%, gained 8.6% over the period.